Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Dermatitis, Contact × Mechlorethamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Hodgkin Disease 9 Lymphoma 8 Lymphoma, T-Cell, Cutaneous 3 Mycosis Fungoides 2 Recurrence 1 Lymphomatoid Papulosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Disease 1 Dermatitis, Contact 1 Central Nervous System Neoplasms 1 Astrocytoma 1

Interventions

Triamcinolone Acetonide 1 Triamcinolone 1 Ointments 1 Mechlorethamine 1 Gels 1 Gelatin 1 Docosahexaenoic Acids 1 Biopsy 1 Amines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03380026 2021-11-24

MIDAS

Rochester Skin Lymphoma Medical Group, PLLC

Phase 2 Completed

28 enrolled 8 charts

DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡